Published in Behav Pharmacol on May 01, 2008
Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat Rev Drug Discov (2009) 6.69
Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol (2010) 4.77
Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol Sci (2008) 3.22
Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature (2012) 2.99
mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning. Neuropsychopharmacology (2009) 1.80
Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders. Nat Rev Drug Discov (2014) 1.51
Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-D-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia. Biol Psychiatry (2010) 1.48
Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5). ACS Chem Neurosci (2011) 1.44
Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B. J Neurosci (2010) 1.33
Loss of object recognition memory produced by extended access to methamphetamine self-administration is reversed by positive allosteric modulation of metabotropic glutamate receptor 5. Neuropsychopharmacology (2010) 1.25
The NMDA receptor as a target for cognitive enhancement. Neuropharmacology (2012) 1.24
Unique signaling profiles of positive allosteric modulators of metabotropic glutamate receptor subtype 5 determine differences in in vivo activity. Biol Psychiatry (2012) 1.22
Development of allosteric modulators of GPCRs for treatment of CNS disorders. Neurobiol Dis (2013) 1.20
Cognitive effects of Group I metabotropic glutamate receptor ligands in the context of drug addiction. Eur J Pharmacol (2010) 1.12
Biased mGlu5-Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu5 Modulation of NMDAR Currents. Neuron (2015) 1.10
Metabotropic glutamate receptors as therapeutic targets for schizophrenia. Neuropharmacology (2011) 1.10
Characterizing cognitive aging of working memory and executive function in animal models. Front Aging Neurosci (2012) 1.09
Methamphetamine self-administration produces attentional set-shifting deficits and alters prefrontal cortical neurophysiology in rats. Biol Psychiatry (2010) 1.08
Targeting glutamate synapses in schizophrenia. Trends Mol Med (2011) 1.06
Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine. Psychopharmacology (Berl) (2011) 1.06
Cognitive enhancers for facilitating drug cue extinction: insights from animal models. Pharmacol Biochem Behav (2011) 1.00
Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders. Molecules (2011) 0.99
Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5). Bioorg Med Chem Lett (2015) 0.92
Distinct manifestations of executive dysfunction in aged rats. Neurobiol Aging (2013) 0.92
Neural structures underlying set-shifting: roles of medial prefrontal cortex and anterior cingulate cortex. Behav Brain Res (2013) 0.92
Functional interaction of mGlu5 and NMDA receptors in aversive learning in rats. Neurobiol Learn Mem (2010) 0.90
Adolescent alcohol exposure reduces behavioral flexibility, promotes disinhibition, and increases resistance to extinction of ethanol self-administration in adulthood. Neuropsychopharmacology (2014) 0.90
The mGluR5 Positive Allosteric Modulator CDPPB Does Not Alter Extinction or Contextual Reinstatement of Methamphetamine-Seeking Behavior in Rats. J Addict Res Ther (2011) 0.87
Therapeutic potential of metabotropic glutamate receptor modulators. Curr Neuropharmacol (2012) 0.85
Clinical physiology and mechanism of dizocilpine (MK-801): electron transfer, radicals, redox metabolites and bioactivity. Oxid Med Cell Longev (2010) 0.83
mGluR5 positive allosteric modulation and its effects on MK-801 induced set-shifting impairments in a rat operant delayed matching/non-matching-to-sample task. Psychopharmacology (Berl) (2014) 0.82
Heterotropic activation of the midazolam hydroxylase activity of CYP3A by a positive allosteric modulator of mGlu5: in vitro to in vivo translation and potential impact on clinically relevant drug-drug interactions. Drug Metab Dispos (2013) 0.82
Anxiety Evokes Hypofrontality and Disrupts Rule-Relevant Encoding by Dorsomedial Prefrontal Cortex Neurons. J Neurosci (2016) 0.82
Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine. Psychopharmacology (Berl) (2012) 0.81
Prefrontal cortical GABAergic signaling and impaired behavioral flexibility in aged F344 rats. Neuroscience (2016) 0.80
Dissociable effects of mGluR5 allosteric modulation on distinct forms of impulsivity in rats: interaction with NMDA receptor antagonism. Psychopharmacology (Berl) (2015) 0.80
Impact of anxiety on prefrontal cortex encoding of cognitive flexibility. Neuroscience (2016) 0.79
Glutamatergic regulation of cognition and functional brain connectivity: insights from pharmacological, genetic and translational schizophrenia research. Br J Pharmacol (2017) 0.79
Metabotropic glutamate receptors: potential drug targets for psychiatric disorders. Open Med Chem J (2010) 0.79
Emerging approaches for treatment of schizophrenia: modulation of glutamatergic signaling. Discov Med (2012) 0.79
Effects of acute administration of the GABA(B) receptor agonist baclofen on behavioral flexibility in rats. Psychopharmacology (Berl) (2016) 0.78
Serum glutamine, set-shifting ability and anorexia nervosa. Ann Gen Psychiatry (2010) 0.78
Glutamate Neurotransmission in Psychotic Disorders and Substance Abuse. Open Psychiatr J (2009) 0.77
Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice. Psychopharmacology (Berl) (2010) 0.77
mGluR5 Positive and Negative Allosteric Modulators Differentially Affect Dendritic Spine Density and Morphology in the Prefrontal Cortex. CNS Neurol Disord Drug Targets (2015) 0.77
Neurophysiology of rule switching in the corticostriatal circuit. Neuroscience (2016) 0.76
Fast and slow transitions in frontal ensemble activity during flexible sensorimotor behavior. Nat Neurosci (2016) 0.76
Deficits in cognitive flexibility induced by chronic unpredictable stress are associated with impaired glutamate neurotransmission in the rat medial prefrontal cortex. Neuroscience (2017) 0.76
Atomoxetine accelerates attentional set shifting without affecting learning rate in the rat. Psychopharmacology (Berl) (2015) 0.76
Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders. Neuron (2017) 0.75
Adaptive encoding of outcome prediction by prefrontal cortex ensembles supports behavioral flexibility. J Neurosci (2017) 0.75
MAM-E17 rat model impairments on a novel continuous performance task: effects of potential cognitive enhancing drugs. Psychopharmacology (Berl) (2017) 0.75
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 8.88
Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci (2000) 5.30
A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models. J Pharmacol Exp Ther (2004) 2.83
Discovery of positive allosteric modulators for the metabotropic glutamate receptor subtype 5 from a series of N-(1,3-diphenyl-1H- pyrazol-5-yl)benzamides that potentiate receptor function in vivo. J Med Chem (2004) 2.46
Involvement of the prelimbic-infralimbic areas of the rodent prefrontal cortex in behavioral flexibility for place and response learning. J Neurosci (1999) 2.45
Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting. Neuropsychopharmacology (2006) 2.19
Glutamate-based therapeutic approaches: allosteric modulators of metabotropic glutamate receptors. Curr Opin Pharmacol (2005) 1.80
NMDA receptors and schizophrenia. Curr Opin Pharmacol (2006) 1.73
Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release. Neuropsychopharmacology (2004) 1.71
Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability. Behav Neurosci (2003) 1.69
(RS)-2-chloro-5-hydroxyphenylglycine (CHPG) activates mGlu5, but no mGlu1, receptors expressed in CHO cells and potentiates NMDA responses in the hippocampus. Neuropharmacology (1997) 1.61
Prelimbic/infralimbic inactivation impairs memory for multiple task switches, but not flexible selection of familiar tasks. J Neurosci (2007) 1.40
Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Ther (2000) 1.39
Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions. Biol Psychiatry (2000) 1.33
Systemic and prefrontal cortical NMDA receptor blockade differentially affect discrimination learning and set-shift ability in rats. Behav Neurosci (2005) 1.33
Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex. Biol Psychiatry (2007) 1.28
The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats. Psychopharmacology (Berl) (2004) 1.21
Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia. Psychopharmacology (Berl) (2005) 1.16
Bursting of prefrontal cortex neurons in awake rats is regulated by metabotropic glutamate 5 (mGlu5) receptors: rate-dependent influence and interaction with NMDA receptors. Cereb Cortex (2005) 1.05
Neuropsychological correlates of opioid dependence and withdrawal. Addict Behav (2003) 0.93
A comparison of cognitive/neuropsychological impairments of nonretarded autistic and schizophrenic children. J Abnorm Child Psychol (1987) 0.86
NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci (2007) 4.35
Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol (2006) 2.73
NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex. Proc Natl Acad Sci U S A (2004) 2.32
Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release. Neuropsychopharmacology (2004) 1.71
Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability. Behav Neurosci (2003) 1.69
Adolescent behavior and dopamine availability are uniquely sensitive to dietary omega-3 fatty acid deficiency. Biol Psychiatry (2013) 1.67
Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats. J Neurophysiol (2004) 1.55
Progression of cellular adaptations in medial prefrontal and orbitofrontal cortex in response to repeated amphetamine. J Neurosci (2006) 1.38
Differential tonic influence of lateral habenula on prefrontal cortex and nucleus accumbens dopamine release. Eur J Neurosci (2008) 1.36
Rule learning and reward contingency are associated with dissociable patterns of dopamine activation in the rat prefrontal cortex, nucleus accumbens, and dorsal striatum. J Neurosci (2006) 1.35
Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. Arch Gen Psychiatry (2002) 1.34
Systemic and prefrontal cortical NMDA receptor blockade differentially affect discrimination learning and set-shift ability in rats. Behav Neurosci (2005) 1.33
Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex. Biol Psychiatry (2007) 1.28
Analysis and design of behavioral experiments to characterize population learning. J Neurophysiol (2004) 1.26
Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology (2002) 1.23
Anterior cingulate neurons represent errors and preparatory attention within the same behavioral sequence. J Neurosci (2009) 1.23
Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychopharmacology (2003) 1.22
Disruption of prefrontal cortex large scale neuronal activity by different classes of psychotomimetic drugs. J Neurosci (2012) 1.18
Orbitofrontal cortex neurons as a common target for classic and glutamatergic antipsychotic drugs. Proc Natl Acad Sci U S A (2008) 1.13
The neurobiology of adolescence: changes in brain architecture, functional dynamics, and behavioral tendencies. Neurosci Biobehav Rev (2011) 1.13
Transient N-methyl-D-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol Psychiatry (2005) 1.08
Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade. Eur J Pharmacol (2010) 1.07
Bursting of prefrontal cortex neurons in awake rats is regulated by metabotropic glutamate 5 (mGlu5) receptors: rate-dependent influence and interaction with NMDA receptors. Cereb Cortex (2005) 1.05
Preparatory attention relies on dynamic interactions between prelimbic cortex and anterior cingulate cortex. Cereb Cortex (2012) 1.04
Adolescents exhibit behavioral differences from adults during instrumental learning and extinction. Behav Neurosci (2010) 1.03
Coordinated activity of ventral tegmental neurons adapts to appetitive and aversive learning. PLoS One (2012) 1.00
Group 5 metabotropic glutamate receptors: role in modulating cortical activity and relevance to cognition. Eur J Pharmacol (2010) 0.98
The influence of NMDA and GABA(A) receptors and glutamic acid decarboxylase (GAD) activity on attention. Psychopharmacology (Berl) (2012) 0.96
Reduced presynaptic dopamine activity in adolescent dorsal striatum. Neuropsychopharmacology (2013) 0.96
Striatum processes reward differently in adolescents versus adults. Proc Natl Acad Sci U S A (2012) 0.95
Stimulus-specific plasticity of prefrontal cortex dopamine neurotransmission. J Neurochem (2004) 0.94
Following the genes: a framework for animal modeling of psychiatric disorders. BMC Biol (2011) 0.94
Fine-tuning of awake prefrontal cortex neurons by clozapine: comparison with haloperidol and N-desmethylclozapine. Biol Psychiatry (2006) 0.94
Reduced neuronal inhibition and coordination of adolescent prefrontal cortex during motivated behavior. J Neurosci (2011) 0.92
Differential representation of Pavlovian-instrumental transfer by prefrontal cortex subregions and striatum. Eur J Neurosci (2009) 0.90
Distinct patterns of plasticity in prefrontal cortex neurons that encode slow and fast responses to stress. Eur J Neurosci (2006) 0.87
NMDA antagonist effects on striatal dopamine release: microdialysis studies in awake monkeys. Synapse (2002) 0.86
Advancing drug discovery for schizophrenia. Ann N Y Acad Sci (2011) 0.86
Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat. Behav Brain Res (2002) 0.86
Distinct prestimulus and poststimulus activation of VTA neurons correlates with stimulus detection. J Neurophysiol (2013) 0.86
Differences in response initiation and behavioral flexibility between adolescent and adult rats. Behav Neurosci (2013) 0.86
Impact of metabotropic glutamate 2/3 receptor stimulation on activated dopamine release and locomotion. Psychopharmacology (Berl) (2010) 0.84
Putative γ-aminobutyric acid neurons in the ventral tegmental area have a similar pattern of plasticity as dopamine neurons during appetitive and aversive learning. Eur J Neurosci (2010) 0.83
Distinct contributions of glutamate receptor subtypes to cognitive set-shifting abilities in the rat. Ann N Y Acad Sci (2003) 0.82
Set shifting in a rodent model of attention-deficit/hyperactivity disorder. Behav Neurosci (2011) 0.82
Improved working memory but no effect on striatal vesicular monoamine transporter type 2 after omega-3 polyunsaturated fatty acid supplementation. PLoS One (2012) 0.81
Glutamatergic animal models of schizophrenia. Curr Pharm Des (2012) 0.80
Research strategies and priorities to improve the lives of people with schizophrenia: executive summary of the Ernst Strüngmann Forum on schizophrenia. Schizophr Bull (2014) 0.77